Effect of WeChat-based intervention of medication adherence on the eradication rate of helicobacter pylori

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800014500

Enrollment

Unknown

Registered

2018-01-17

Start date

2018-02-01

Completion date

Unknown

Last updated

2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

O2:WeChat & Dual therapy

C2:Dual therapy

O4:WeChat &Quadruple therapy

C4:Quadruple therapy

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patients with H. pylori infection; 2. Aged 18 to 70 years; 3. Never received treatment for H. pylori infection; 4. Willing and to be available to participate this study.

Exclusion criteria

Exclusion criteria: pregnancy, breast-feed, serious diseases,malignancy, the study drug allergy, severe ulcer bleeding or perforation, not the first time for helicobacter prlori eradication, taking PPIs or antibiotics within the past 4 weeks, Any other clinically significant medical condition that could increase risk of side effects.

Design outcomes

Primary

Measure	Time frame
medication adherence;eradication rate;	—

Secondary

Measure	Time frame
adverse effect;	—

Countries

China

Contacts

Public ContactShengxi Han

hsx8934@sina.com+86 028-87394648

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026